278 filings
Page 3 of 14
8-K
837u6i1iweed aaqj93
4 May 22
Fate Therapeutics Reports First Quarter 2022 Financial Results and Highlights Operational Progress
4:06pm
DEFA14A
5k2yoorq lz5jahsw3bf
25 Apr 22
Additional proxy soliciting materials
4:07pm
S-8
ahi1s p4lkp
28 Feb 22
Registration of securities for employees
5:12pm
8-K
828xwepfe4ywl 1xda1
28 Feb 22
Fate Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Operational Progress
4:06pm
8-K
g3ni4uy6
14 Dec 21
Other Events
5:28pm
8-K
yanu7lx96eec
4 Nov 21
Entry into a Material Definitive Agreement
4:59pm
S-3ASR
3kkf4qaczbex8xt
4 Nov 21
Automatic shelf registration
4:56pm
8-K
unhowct4p6x1eb96
4 Nov 21
Fate Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Operational Progress
4:07pm
8-K
c4j2ntij3jfh61iqz
4 Aug 21
Fate Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Operational Progress
4:05pm
8-K
glg31fdsc6s0 4t
4 Aug 21
Fate Therapeutics Appoints Yuan Xu to its Board of Directors
9:20am
8-K
fnuzhdzemou9e
7 Jun 21
Amendments to Articles of Incorporation or Bylaws
4:50pm
8-K
kuvpjug
5 May 21
Fate Therapeutics Reports First Quarter 2021 Financial Results and Highlights Operational Progress
4:01pm
DEFA14A
2kzj5d9pam 9u
21 Apr 21
Additional proxy soliciting materials
4:13pm